Tender

PR BHFT 0535 - Nonchemotherapy Compounded Monoclonal Antibodies

  • Berkshire Healthcare NHS Foundation Trust

F02: Contract notice

Notice identifier: 2024/S 000-031917

Procurement identifier (OCID): ocds-h6vhtk-04a5f9

Published 4 October 2024, 2:56pm



The closing date and time has been changed to:

8 November 2024, 10:00am

See the change notice.

Section one: Contracting authority

one.1) Name and addresses

Berkshire Healthcare NHS Foundation Trust

London House, London Road

Bracknell

RG12 2UT

Contact

Mike Pollard

Email

mike.pollard@berkshire.nhs.uk

Country

United Kingdom

Region code

UKJ11 - Berkshire

Internet address(es)

Main address

https://www.berkshirehealthcare.nhs.uk/

Buyer's address

https://www.berkshirehealthcare.nhs.uk/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://health-family.force.com/s/Welcome

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://health-family.force.com/s/Welcome

Tenders or requests to participate must be submitted to the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://health-family.force.com/s/Welcome

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

PR BHFT 0535 - Nonchemotherapy Compounded Monoclonal Antibodies

Reference number

PR BHFT 0535

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Pharmacy Procurement Contract - Supply of Nonchemotherapy Compounded Monoclonal Antibodies. A Ranked Framework split into three LOTS
LOT 1 - Infliximab Compounded Dose Banded Bags
LOT 2 - Vedolizumab Compounded Bags
LOT 3 - Natalizumab Compounded Bags

two.1.5) Estimated total value

Value excluding VAT: £4,800,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Pharmacy Procurement Contract - Supply of Nonchemotherapy Compounded Monoclonal Antibodies. A Ranked Framework split into three LOTS
LOT 1 - Infliximab Compounded Dose Banded Bags
LOT 2 - Vedolizumab Compounded Bags
LOT 3 - Natalizumab Compounded Bags
The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service
Thames Valley and Wessex:
Berkshire Healthcare NHS Foundation Trust
Buckinghamshire Healthcare NHS Trust
Dorset County Hospital NHS Foundation Trust
Dorset HealthCare University NHS Foundation Trust
Hampshire Hospitals NHS Foundation Trust
Frimley Health NHS Foundation Trust
Isle of Wight NHS Trust
Milton Keynes NHS Foundation Trust
Oxford Health NHS Foundation Trust
Oxford University Hospital NHS Trust*
Poole Hospital NHS Foundation Trust
Portsmouth Hospitals NHS Trust
Royal Berkshire NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Hampshire & Isle of Wight NHS Foundation Trust
University Hospital Southampton NHS Foundation Trust
South East Coast:
Ashford and St Peters Hospital NHS Foundation Trust
Brighton and Sussex University Hospitals NHS Trust
Dartford and Gravesham NHS Trust
East Kent Hospitals NHS Foundation Trust
East Sussex Healthcare NHS Trust
Kent Community Health NHS Trust
Maidstone and Tunbridge Wells NHS Trust
Medway NHS Trust
Queen Victoria Hospitals NHS Foundation Trust
Royal Surrey County Hospital NHS Foundation Trust
Surrey and Borders Partnership NHS Foundation Trust
Surrey and Sussex Healthcare NHS Trust
Sussex Community NHS Trust
Sussex Partnership NHS Foundation Trust
Western Sussex Hospitals NHS Foundation Trust
For the avoidance of doubt, any successor bodies of any of the above entities shall be entitled to place Orders and shall be deemed Participating Authorities for the purposes of this Framework Agreement.
Due to the evolving structure of the NHS, other NHS organisations to which the NHS Trusts listed above are affiliated or become affiliated will be granted access to this framework, for example Integrated Care Systems (ICSs) and Primary Care Networks (PCNs).

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

24

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

Option for 2 x 12 month extension (maximum duration 4 years)

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Originally published as:

Date

5 November 2024

Local time

10:00am

Changed to:

Date

8 November 2024

Local time

10:00am

See the change notice.

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

5 November 2024

Local time

10:00am


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

The High Court of England and Wales

The Royal Court of Justice, The Strand

London

WC2A 2LL

Country

United Kingdom